Indications
Narrow complex tachycardias: stable SVT, and stable A-fib, atrial flutter or multifocal atrial tachycardia.
Contraindications
Hypersensitivity. When given for hypertension or angina: sinus bradycardia, second- or third-degree AV block, cardiogenic shock, sick sinus syndrome without a permanent pacemaker, severe peripheral vascular disease, pheochromocytoma. When given for MI: heart rate less than 45, SBP less than 100 mmHg, significant first-degree heart block (PR interval at least 0.24 seconds), moderate to severe cardiac failure.
Adult dose
Stable SVT, or stable A-fib, atrial flutter or MAT: 5 mg IV over 1-2 minutes. May repeat every 5 minutes as needed, for a total of 3 doses.
Pediatric dose
No pediatric dose in the national guidelines. Follow local protocol.
Route
IV, IO
Special considerations
Know the SBP first: give it only when it is greater than 120 mmHg.
It can worsen CHF, COPD and asthma, and it can cause hypotension, bradycardia and AV block.
Give it with a calcium channel blocker such as diltiazem and you raise the risk of hypotension and bradycardia.
Avoid it in pre-excited A-fib and irregular wide complex tachycardia (WPW, LGL). In those rhythms, an AV nodal blocker can cause a paradoxical rise in the ventricular rate.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Tachycardia with a Pulse; Purpose and Notes. Levels from the National EMS Scope of Practice Model (2019).